ProCE Banner Activity

Antibody‒Drug Conjugates and Their Role in TROP2-Expressing Tumors

Slideset

Download this slideset from a live CCO symposium for nurses to get an introduction to the TROP2 ADCs sacituzumab govitecan and datopotamab deruxtecan.

Released: April 28, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.